Načítá se...
Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges
Oncolytic viruses have emerged as a promising strategy for cancer therapy due to their dual ability to selectively infect and lyse tumor cells and to induce systemic anti-tumor immunity. Among various candidate viruses, coxsackievirus group B (CVBs) have attracted increasing attention in recent year...
Uloženo v:
| Vydáno v: | Viruses |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8227215/ https://ncbi.nlm.nih.gov/pubmed/34198859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13061082 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|